Case Report: A 55 kg retroperitoneal liposarcoma
While Complete surgical resection (R0) remains the gold standard for RPLS management, radical multivisceral resection of massive tumors requires meticulous evaluation by a multidisciplinary team (MDT), encompassing patient fitness, tumor biology, and perioperative risk stratification. When achieving R0 resection is deemed unfeasible or carries prohibitive risks, staged debulking surgery may be considered as an alternative approach. The application of hyperthermic intraperitoneal chemotherapy (HIPEC) should be evaluated judiciously on a case-by-case basis.
Authors
- D.D. Long
- Yang Yang (ORCID: https://orcid.org/0000-0001-7432-4735)
- Dong Yong-hong
- Linlin Jiang
- Xiaogang Bi (ORCID: https://orcid.org/0000-0003-1954-1651)
- Ren Yingzheng
- An Junjie
- Wang Guifei
- Fang Zhiqiang
Institutions
- Shanxi Medical University (CN)
- Shanxi Province Hospital of Traditional Chinese Medicine (CN)
- Shanxi Provincial Children's Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
- Shanxi Cardiovascular Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.3389/fonc.2025.1621829
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Wu Jieping Medical Foundation